These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1180 related items for PubMed ID: 15318857

  • 21. Italian blood donors with anti-HBc and occult hepatitis B virus infection.
    Manzini P, Girotto M, Borsotti R, Giachino O, Guaschino R, Lanteri M, Testa D, Ghiazza P, Vacchini M, Danielle F, Pizzi A, Valpreda C, Castagno F, Curti F, Magistroni P, Abate ML, Smedile A, Rizzetto M.
    Haematologica; 2007 Dec; 92(12):1664-70. PubMed ID: 18055990
    [Abstract] [Full Text] [Related]

  • 22. [Study about seroconversion of HBV NAT screening-positive crowd from blood donors].
    Wang DW, Wang TB, Liu FP, Shi LL.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):127-9. PubMed ID: 18574536
    [Abstract] [Full Text] [Related]

  • 23. Occult hepatitis B virus infection among anti-HBc positive blood donors: Necessitates substitution of screening by HBV NAT.
    Panhotra BR, Bahrani A, Joshi CS, ul Hassan Z.
    J Infect; 2005 Oct; 51(3):263. PubMed ID: 16125778
    [No Abstract] [Full Text] [Related]

  • 24. Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT.
    Brojer E, Grabarczyk P, Liszewski G, Mikulska M, Allain JP, Letowska M, Polish Blood Transfusion Service Viral Study Group.
    Hepatology; 2006 Dec; 44(6):1666-74. PubMed ID: 17133474
    [Abstract] [Full Text] [Related]

  • 25. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
    Kiely P, Margaritis AR, Seed CR, Yang H, Australian Red Cross Blood Service NAT Study Group.
    Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170
    [Abstract] [Full Text] [Related]

  • 26. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L, Chen PJ, Chen MH, Chak KF, Lin KS, Tsai SJ.
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [Abstract] [Full Text] [Related]

  • 27. Detection of HBV DNA by nested-PCR in a HBsAg and anti-HBc negative blood bank donor.
    Almeida RP, Cardoso DD.
    J Clin Virol; 2006 Jul; 36(3):231-4. PubMed ID: 16574475
    [Abstract] [Full Text] [Related]

  • 28. Blood donor screening in the Netherlands: Universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing.
    van de Laar TJ, Hogema BM, Molenaar-de Backer MW, Marijt-van der Kreek T, Zaaijer HL.
    Transfusion; 2021 Jul; 61(7):2116-2124. PubMed ID: 33899233
    [Abstract] [Full Text] [Related]

  • 29. Nucleic acid amplification technology for hepatitis B virus, and its role in blood donation screening in blood banks.
    Bamaga MS, Azahar EI, Al-Ghamdi AK, Alenzi FQ, Farahat FM.
    Saudi Med J; 2009 Nov; 30(11):1416-21. PubMed ID: 19882053
    [Abstract] [Full Text] [Related]

  • 30. [Investigation of the presence of HBV-DNA in isolated anti-HBc positive cases and their importance in blood banking].
    Bal SH, Heper Y, Kumaş LT, Mistik R, Töre O.
    Mikrobiyol Bul; 2009 Apr; 43(2):243-50. PubMed ID: 19621609
    [Abstract] [Full Text] [Related]

  • 31. Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain.
    González R, Torres P, Castro E, Barbolla L, Candotti D, Koppelman M, Zaaijer HL, Lelie N, Allain JP, Echevarría JM.
    Transfusion; 2010 Jan; 50(1):221-30. PubMed ID: 19682332
    [Abstract] [Full Text] [Related]

  • 32. A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases.
    Laperche S, Maniez M, Barlet V, El Ghouzzi MH, Le Vacon F, Levayer T, Lunel F, Morel P, Mouillot L, Piquet Y, Pillonel J, Transfusion-Transmissible Agents Working Group, French National Society of Blood Transfusion.
    Transfusion; 2008 Nov; 48(11):2308-14. PubMed ID: 18673347
    [Abstract] [Full Text] [Related]

  • 33. New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods.
    Kuhns MC, Busch MP.
    Mol Diagn Ther; 2006 Nov; 10(2):77-91. PubMed ID: 16669606
    [Abstract] [Full Text] [Related]

  • 34. Significance of detecting anti-HBc among Egyptian male blood donors negative for HBsAg.
    Antar W, El-Shokry MH, Abd El Hamid WA, Helmy MF.
    Transfus Med; 2010 Dec; 20(6):409-13. PubMed ID: 20573069
    [Abstract] [Full Text] [Related]

  • 35. [Natural history of hepatitis B virus infection in dialysis patients: prospective study by quantitative analysis of HBV viremia].
    Fabrizi F, Lunghi G, Finazzi S, Colucci P, Pagliari B, Bisegna S, Tettamanzi F, Ponticelli C.
    G Ital Nefrol; 2002 Dec; 19(3):294-300. PubMed ID: 12195397
    [Abstract] [Full Text] [Related]

  • 36. Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels.
    Assal A, Barlet V, Deschaseaux M, Dupont I, Gallian P, Guitton C, Morel P, van Drimmelen H, David B, Lelie N, De Micco P.
    Transfusion; 2009 Feb; 49(2):301-10. PubMed ID: 19389212
    [Abstract] [Full Text] [Related]

  • 37. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
    Altindiş M, Uslan I, Cetinkaya Z, Yüksel S, Ciftçi IH, Demirtürk N, Ozdemir M, Arslan F, Aktepe OC.
    Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
    [Abstract] [Full Text] [Related]

  • 38. Hepatitis B virus DNA in serum of 'anti-HBc only'-positive healthy Lebanese blood donors: significance and possible implications.
    El-Zaatari M, Kazma H, Naboulsi-Majzoub M, Haidar M, Ramlawi F, Mahfoud Z, Ramia S.
    J Hosp Infect; 2007 Jul; 66(3):278-82. PubMed ID: 17540476
    [Abstract] [Full Text] [Related]

  • 39. Nucleic acid testing to detect HBV infection in blood donors.
    Stramer SL, Wend U, Candotti D, Foster GA, Hollinger FB, Dodd RY, Allain JP, Gerlich W.
    N Engl J Med; 2011 Jan 20; 364(3):236-47. PubMed ID: 21247314
    [Abstract] [Full Text] [Related]

  • 40. PRISM hepatitis B surface antigen detection of hepatits B virus minipool nucleic acid testing yield samples.
    Linauts S, Saldanha J, Strong DM.
    Transfusion; 2008 Jul 20; 48(7):1376-82. PubMed ID: 18422847
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 59.